China CRO Outsourcing Market Analysis
India's first complete product patent law, generic drugs, narrow path, making it India's leading pharmaceutical companies from a reverse-engineering to drug discovery paradigm shift. At the same time, the Indian government R & D Contract Research Outsourcing blog enterprise through the provision of financial incentives to encourage innovation. In the recently submitted budget, according to R & D expenses 150% plus the offset measures will be extended to 2015. In addition, the Science and Technology has developed a number of encouraging the development of the country's development plans.Obstetrics and gynecology
India's pharmaceutical R & D begins to achieve a useful transformation, more and more multinational pharmaceutical companies choice and innovative companies in India in the form of alliances or joint ventures to take advantage of the country's scientific research personnel, cost, time efficiency, policy, and advantages of the disease groups.http://crolegacy.com/category/biocompatibility-of-the-advisory
It should be said, policy guide and encourage enterprises voluntarily develop new medicines, and multinational cooperation, these are the growth of the Indian CRO Outsourcing positive elements.Robert biological products
In contrast, China is currently in the three aspects, there are still lacking and inadequate.
